JP2024504903A5 - - Google Patents

Info

Publication number
JP2024504903A5
JP2024504903A5 JP2023533392A JP2023533392A JP2024504903A5 JP 2024504903 A5 JP2024504903 A5 JP 2024504903A5 JP 2023533392 A JP2023533392 A JP 2023533392A JP 2023533392 A JP2023533392 A JP 2023533392A JP 2024504903 A5 JP2024504903 A5 JP 2024504903A5
Authority
JP
Japan
Prior art keywords
antigen
binding molecule
antibody
binding
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023533392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504903A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/003299 external-priority patent/WO2022163809A1/en
Publication of JP2024504903A publication Critical patent/JP2024504903A/ja
Publication of JP2024504903A5 publication Critical patent/JP2024504903A5/ja
Pending legal-status Critical Current

Links

JP2023533392A 2021-01-29 2022-01-28 細胞死が観察される組織において特異的に作用する分子 Pending JP2024504903A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2021013586 2021-01-29
JP2021013586 2021-01-29
EP21211440 2021-11-30
EP21211440.9 2021-11-30
EP22151665 2022-01-14
EP22151665.1 2022-01-14
PCT/JP2022/003299 WO2022163809A1 (en) 2021-01-29 2022-01-28 Molecule specifically acting in a tissue where a cell death being observed

Publications (2)

Publication Number Publication Date
JP2024504903A JP2024504903A (ja) 2024-02-02
JP2024504903A5 true JP2024504903A5 (https=) 2025-02-04

Family

ID=82653502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023533392A Pending JP2024504903A (ja) 2021-01-29 2022-01-28 細胞死が観察される組織において特異的に作用する分子

Country Status (4)

Country Link
US (1) US20220251166A1 (https=)
EP (1) EP4284835A4 (https=)
JP (1) JP2024504903A (https=)
WO (1) WO2022163809A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150672A1 (en) * 2022-02-04 2023-08-10 Duke University Compositions for and methods of treating hematological cancers
CN119731210A (zh) 2022-04-21 2025-03-28 弗朗西斯克里克研究所有限公司 双特异性结合剂
CN119630793A (zh) * 2022-07-28 2025-03-14 中外制药株式会社 在观察到细胞死亡的组织中特异性地起作用的分子
GB202401381D0 (en) 2024-02-02 2024-03-20 Francis Crick Institute Ltd Anti-actin antibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130552B1 (en) * 2007-02-27 2016-06-15 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising anti-grp78 antibody as active ingredient
WO2013048243A1 (en) * 2011-09-29 2013-04-04 Apo-T B.V. Multi-specific binding molecules targeting aberrant cells
US20190336615A1 (en) * 2017-01-27 2019-11-07 Silverback Therapeutics, Inc. Tumor targeting conjugates and methods of use thereof
AU2018313810B2 (en) * 2017-08-09 2025-05-15 Orionis Biosciences BV Clec9A binding agents and use thereof
JPWO2019244973A1 (ja) * 2018-06-20 2021-07-08 中外製薬株式会社 標的細胞に対する免疫反応を活性化する方法およびその組成物
EP4021966A4 (en) * 2019-08-26 2023-09-13 Greene, Tweed Technologies, Inc. FLUORINE-CONTAINING ELASTOMER COMPOSITIONS WITH MICRODIAMANT
CN116322763A (zh) * 2020-08-27 2023-06-23 学校法人顺天堂 抗切断型突变calr-cd3双特异性抗体及医药组合物

Similar Documents

Publication Publication Date Title
JP2024504903A5 (https=)
US9304127B2 (en) Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment for use in therapy
Roux Immunoglobulin structure and function as revealed by electron microscopy
CN108368166B (zh) 提高含fc区多肽纯化效率的方法
KR102249078B1 (ko) 요법에 사용하기 위한 항-아드레노메둘린 (adm) 항체 또는 항-adm 항체 단편 또는 항-adm 비-ig 스캐폴드
JP2019522490A5 (https=)
JP2010516747A5 (https=)
CN109942709B (zh) 一种抗bcma的单域抗体及其应用
JP2020195399A5 (https=)
JP2022512653A5 (https=)
JP2020500510A5 (https=)
Sheng et al. Separation of antigens and antibodies by immunoaffinity chromatography
RU2014102007A (ru) Методы предсказания, обнаружения и уменьшения неспецифической интерференции белков в способах анализа с использованием одиночных вариабельных доменов иммуноглобулинов
JP2024023228A5 (https=)
CN109790210B (zh) 包含重组人类cd38细胞外结构域的组合物、方法和/或试剂盒
JP2015528003A5 (https=)
Bach et al. Purification of small nuclear ribonucleoprotein particles with antibodies against modified nucleosides of small nuclear RNAs
JP2020007318A5 (https=)
JP2023553697A5 (https=)
Tsuneoka et al. Monoclonal antibody against non-histone chromosomal protein high mobility group 1 Co-migrates with high mobility group 1 into the nucleus.
EP2780371A1 (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
WO2019144677A1 (zh) 抗ox40抗体及其用途
Muronetz et al. Isolation of antigens and antibodies by affinity chromatography
JP2024547218A5 (https=)
JP2002544237A5 (https=)